Skip to main content
Betta Pharmaceuticals Co.,Ltd logo

Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings

Ticker · 300558 ISIN · CNE100002DD9 LEI · 8368009YF4Y6NC7HVB09 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,653 across all filing types
Latest filing 2024-08-05 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300558

About Betta Pharmaceuticals Co.,Ltd

https://www.bettapharma.com

Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.

Recent filings

Filing Released Lang Actions
2024年半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 85% confidence The document is a summary table of non-operating fund occupation and other related party fund transactions for the half-year period of 2024. It includes detailed financial figures such as balances at the beginning and end of the period, cumulative amounts, and interest related to these transactions. The document is relatively short (1672 characters) and contains specific financial data for the half-year period, indicating it is a financial report rather than just an announcement. The content focuses on related party transactions and fund usage, which is typical of interim or quarterly financial disclosures. There is no indication that this is a full annual report, audit report, or earnings release. Given the half-year period and the detailed financial data, the document best fits the category of an Interim / Quarterly Report (IR).
2024-08-05 Chinese
2024年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2024 半年度报告摘要" which translates to "2024 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, cash flow, and shareholder information for the half-year period. The content includes comprehensive financial metrics, business performance, and operational highlights for the reporting period. The length of the document (7601 characters) and the presence of substantive financial data and analysis confirm it is a financial report rather than a brief announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2024-08-05 Chinese
关于股东股份质押变动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding changes in shareholder stock pledge status. It details the number of shares pledged, pledge start and end dates, pledgees, and the impact on the company's shareholding structure. There is no financial statement, earnings data, or management discussion. The document is short (2223 characters) and focuses on a specific shareholder pledge event. This fits the category of a Regulatory Filing (RNS) as it is a regulatory disclosure about share pledge changes and does not fit other more specific categories like Capital/Financing Update (CAP) because it states no new financing is involved, nor is it a Director's Dealing (DIRS) or Share Issue/Capital Change (SHA). Therefore, the best classification is Regulatory Filings (RNS).
2024-07-30 Chinese
关于股东股份质押变动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding changes in shareholder stock pledge status, specifically detailing the pledge of shares by a major shareholder and related risk disclosures. It includes tables of shareholding and pledge ratios, pledge start and end dates, and assurances about the impact on company control and operations. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge changes, which fits the category of Regulatory Filings (RNS) as it does not match more specific categories like Capital/Financing Update (CAP) or Major Shareholding Notification (MRQ) since it focuses on pledge changes rather than share ownership thresholds or capital raising. The document length is short and it is a formal disclosure to the market about share pledge status.
2024-07-25 Chinese
关于股东股份质押变动的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding changes in shareholder stock pledges. It details the pledge status, pledge extensions, and releases of shares by a major shareholder. The content focuses on share pledge changes, risk assessments, and related shareholder information. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledge changes, which fits the category of Major Shareholding Notification (MRQ) as it involves significant share ownership and pledge status changes by a controlling shareholder. The document length is short and it is not a report or certification, so it is not a report publication announcement or regulatory filing. Therefore, the best classification is MRQ with high confidence.
2024-07-24 Chinese
2024年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2024 half-year performance forecast (业绩预告) for the period January 1, 2024 to June 30, 2024. It contains preliminary estimated financial results (net profit and growth percentages) but explicitly states that the data is preliminary, unaudited, and will be detailed in the upcoming half-year report. The document is short (920 characters) and serves as an earnings preview rather than a full interim report with substantive financial statements. Therefore, it fits the definition of an Earnings Release (ER) as it announces key highlights of quarterly/periodical financial results without full financial statements or detailed analysis.
2024-07-23 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.